Novel vitamin D analogs as potential therapeutics: Metabolism, toxicity profiling, and antiproliferative activity

J. Chen, J. Wang, T. Kim, Elaine Tieu, Edith Tang, Z. Lin, D. Kovacic, D.D. Miller, A.E. Postlethwaite, Robert Tuckey, A.T. Słomiński, W. Li.

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Aim: To discover novel [20(OH)D3] analogs as antiproliferative therapeutics. Materials and Methods: We studied in vitro liver microsome stability, in vivo toxicity using mice, vitamin D receptor (VDR) translocation, in vitro antiproliferative effect, CYP enzyme metabolism. Results: 20S-And 20R(OH)D3 had reasonable half-lives of 50 min and 30 min (average) respectively in liver microsomes. They were non-hypercalcemic at a high dose of 60 ìg/kg. Three new 20(OH)D3 analogs were designed, synthesized and tested. They showed higher or comparable potency for inhibition of proliferation of normal keratinocytes and in the induction of VDR translocation from cytoplasm to nucleus, compared to 1,25(OH)2D3. These new analogs demonstrated different degrees of metabolism through a range of vitamin D-metabolizing CYP enzymes. Conclusion: Their lack of calcemic toxicity at high doses and their high biological activity suggest that this novel 20(OH)D3 scaffold may represent a promising platform for further development of therapeutically-useful agents.
Original languageEnglish
Pages (from-to)2153-2164
JournalAnticancer Research
Volume34
Issue number5
Publication statusPublished - 2014

Fingerprint Dive into the research topics of 'Novel vitamin D analogs as potential therapeutics: Metabolism, toxicity profiling, and antiproliferative activity'. Together they form a unique fingerprint.

Cite this